In conclusion, these in vivo and in vitro experiments elucidated the molecular mechanism of genistein in PD treatment, highlighting its role in attenuating inflammatory responses and oxidative damage, as well as modulating caspase-8 and caspase-3 expression. The gene discussed is CASP8; the disease is Parkinson disease.